Back to top
more

LeMaitre Vascular (LMAT)

(Delayed Data from NSDQ)

$89.04 USD

89.04
71,407

-0.82 (-0.91%)

Updated Aug 28, 2024 04:00 PM ET

After-Market: $89.05 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (98 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Zacks.com highlights: Stamps.com, ICU Medical, LeMaitre Vascular, United States Cellular and Everest Re Group

Zacks.com highlights: Stamps.com, ICU Medical, LeMaitre Vascular, United States Cellular and Everest Re Group

    Boost Immunity to Market Volatility With 5 Low-Beta Stocks

    We have developed a strategy which clearly shows that stocks with low risk could also reward investors with handsome returns.

      Stryker (SYK) to Gain From Solid Portfolio and Acquisitions

      Stryker's (SYK) diverse portfolio and accretive acquisitions is instrumental in aiding the company's top-line growth.

        Stryker (SYK) to Gain From Solid Portfolio and Acquisitions

        Stryker Corporation (SYK) has successfully expanded its product portfolio over time, which aids the company to cater to evolving demands of customers.

          Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength

          Luminex Corp (LMNX) is focusing on augmenting its portfolio strength through new FDA approvals.

            5 MedTech Stocks to Pick for Stellar Returns

            While the MedTech industry has been grappling with multiple issues, these stocks with high growth potential can be great bets.

              5 Top-Ranked MedTech Growth Stocks for Solid Returns

              Despite the ongoing turmoil in the MedTech industry, these stocks with high growth potential can be great bets for investors.

                Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead

                The share price performance of Abbott Laboratories (ABT) has been disappointing over the last three years. Of the prime issues plaguing Abbott, foreign exchange is a major one.

                  Why LeMaitre Vascular (LMAT) Could Be Positioned for a Surge

                  LeMaitre Vascular (LMAT) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.

                    Top Ranked Momentum Stocks to Buy for August 8th

                    Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 8th:

                      LeMaitre Vascular (LMAT) Worth a Look: Stock Jumps 19.5%

                      LeMaitre Vascular, Inc. (LMAT) shares jumped above 19% in the last trading session.

                        Top Ranked Momentum Stocks to Buy for July 31st

                        Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 31st:

                          Time to Focus on LeMaitre Vascular (LMAT) for Strong Earnings Growth Potential

                          LeMaitre Vascular (LMAT) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

                            7 Stocks to Buy with Impressive Interest Coverage Ratio

                            A company's fundamentals should be sound enough to meet its financial obligations. This can be judged through coverage ratios.

                              Can The Uptrend Continue for LeMaitre Vascular (LMAT)?

                              Investors certainly have to be happy with LeMaitre Vascular Inc (LMAT) and its short term performance

                                Top Ranked Momentum Stocks to Buy for April 28th

                                Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 28th:

                                  Medical Device Stocks to Beat Estimates this Earnings Season

                                  Most of the MedTech majors will be releasing earnings later this month.

                                    Kevin Matras headshot

                                    Get Ready To Be Surprised This Earnings Season

                                    Kevin Matras details a good screen to use before and after a company reports this earnings season. Highlighted stocks include COR, LMAT, TSO, ATVI and TECD.